The legislation is sponsored by Senators Susan Collins (R-Maine) and Claire McCaskill (D-Mo.).
“The ‘Increasing Competition in Pharmaceuticals Act’ is an important step toward fostering a more competitive generic drug marketplace and ensuring patient access to affordable medications,” said HSCA President and CEO Todd Ebert. “HSCA applauds Senators Collins and McCaskill for their leadership on S.2615 and we support the legislation’s mandated priority review of abbreviated new drug applications for generic drugs made by just one manufacturer. Healthcare group purchasing organizations have a unique line of sight on the healthcare supply chain, and we look forward to continuing to serve as a resource to the Senate Special Committee on Aging as they work to advance S.2615.”
More articles on supply chain management:
Create an unbreakable supply chain in the eye of the storm
Medline is now HDG’s prime vendor for various supplies and value-added programs: 4 things to know
Northside Hospital awards supply chain contract to Medline: 3 facts
